Skip to main content

Table 2 Clinical characteristics by asthma inflammatory phenotypes

From: Galectin-3 enhances monocyte-derived macrophage efferocytosis of apoptotic granulocytes in asthma

 

EA

NEA

p value

n

8

7

 

Age, years

53.7 (±13.0)

49.7 (±22.0)

0.672

Sex, male (%)

1 (13)

2 (29)

0.438

BMI

33.7 (±4.7)

28.8 (±3.9)

0.057

Atopy, n (%)

5 (83)

3 (60)

0.387

Ex-smoker, n(%)

3 (38)

1 (14)

0.310

Pack years

4.8 (±6.3)

59.1

–

Exhaled CO (ppm)

4 (3, 7)

2 (2, 3)

0.051

FEV1 predicted (%)

84.9 (69.7, 102.3)

101.9 (82.5, 105.9)

0.189

FEV1/FVC (%)

92.0 (±16.1)

97.3 (±15.3)

0.522

Taking ICS, n (%)

7 (89)

6 (86)

0.919

ICS dose (μg/day)

1000 (800, 1000)

1000 (750, 1625)

0.422

ACQ6 score

1.3 (0.5, 2.3)

0.7 (0.2, 0.8)

0.112

  1. Data is reported as mean ± SD or median (q1, q3). Data was analysed by the unpaired t test and Mann-Whitney U test. The two-sample test of proportions was used to compare proportions. ACQ6: asthma control questionnaire 6; BMI: body mass index; CO: carbon monoxide; FEV1: forced expiratory volume in one second; FVC: forced vital capacity; ICS: inhaled corticosteroid